Review of the Use of Botulinum Toxin in the Setting of Back Pain

被引：0

作者：

Jung J.H. ^{[1
]}

Bilezikjian M.A. ^{[2
]}

机构：

[1] Department of Orthopaedics, Physical Medicine and Rehabilitation, The UCLA Spine Center, David Geffen School of Medicine, 1250 16th Street, Suite 3145H, Santa Monica, 90404, CA

[2] Physical Medicine and Rehabilitation, Johns Hopkins School of Medicine, Baltimore, MD

来源：

Current Physical Medicine and Rehabilitation Reports | 2013年 / 1卷 / 2期

关键词：

Botox; Botulinum toxin; Low back pain; Myofascial pain; Neck pain;

D O I：

10.1007/s40141-013-0009-y

中图分类号：

学科分类号：

摘要：

The current understanding of the pathophysiology of myofascial pain and the mechanism of botulinum neurotoxin (BoNT) suggest that BoNT may be well suited to the treatment of back pain. The few randomized controlled trials that have been done to evaluate the efficacy of BoNT in the treatment of myofascial low back pain have shown some promising results. Results from the more numerous trials of BoNT for treatment of myofascial thoracic and neck pain have only shown trends toward the efficacy of BoNT treatments compared with control treatments. © 2013, Springer Science + Business Media New York.

引用

页码：114 / 119

页数：5

共 18 条

[1]

Luo X., Pietrobon R., Sun S.X., Liu G.G., Hey L., Estimates and patterns of direct health care expenditures among individuals with back pain in the United States, Spine (Phila Pa 1976), 29, 1, pp. 79-86, (2004)

[2]

Manchikanti L., Singh V., Datta S., Cohen S.P., Hirsch J.A., Comprehensive review of epidemiology, scope, and impact of spinal pain, Pain Physician, 12, 4, pp. E35-E70, (2009)

[3]

Cote P., van der Velde G., Cassidy J.D., Carroll L.J., Hogg-Johnson S., Holm L.W., Et al., The burden and determinants of neck pain in workers: results of the Bone and Joint Decade 2000–2010 Task Force on Neck Pain and Its Associated Disorders, Spine (Phila Pa 1976), 33, pp. 60-74, (2008)

[4]

Hart L.G., Deyo R.A., Cherkin D.C., Physician office visits for low back pain. Frequency, clinical evaluation, and treatment patterns from a U.S. national survey, Spine (Phila Pa 1976), 20, 1, pp. 11-19, (1995)

[5]

Manchikanti L., Health care reform in the United States: radical surgery needed now more than ever, Pain Physician, 11, 1, pp. 13-42, (2008)

[6]

Borg-Stein J., Simons D.G., Focused review: Myofascial pain, Arch Phys Med Rehabil., 83, 1, pp. S40-S47, (2002)

[7]

Jankovic J., Schwartz K., Botulinum toxin injections for cervical dystonia, Neurology, 40, 2, pp. 277-280, (1990)

[8]

Ishikawa H., Mitsui Y., Yoshitomi T., Mashimo K., Aoki S., Mukuno K., Et al., Presynaptic effects of botulinum toxin type A on the neuronally evoked response of albino and pigmented rabbit iris sphincter and dilator muscles, Jpn J Ophthalmol, 44, 2, pp. 106-109, (2000)

[9]

de Andres J., Adsuara V.M., Palmisani S., Villanueva V., Lopez-Alarcon M.D., A double-blind, controlled, randomized trial to evaluate the efficacy of botulinum toxin for the treatment of lumbar myofascial pain in humans, . Reg Anesth Pain Med, 35, 3, pp. 255-260, (2010)

[10]

Fishman L.M., Anderson C., Rosner B., BOTOX and physical therapy in the treatment of piriformis syndrome, Am J Phys Med Rehabil, 81, 12, pp. 936-942, (2002)

← 1 2 →